These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 35705678)

  • 1. Cytotoxic effects of targeted agent alone or with chemotherapy in the treatment of adenoid cystic carcinoma: a preclinical study.
    Savarese T; Abate A; Basnet RM; Lorini L; Gurizzan C; Tomasoni M; Lombardi D; Tomasini D; Zizioli D; Memo M; Berruti A; Bonini SA; Sigala S; Bossi P
    Sci Rep; 2022 Jun; 12(1):9951. PubMed ID: 35705678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of cyclophosphamide, doxorubicin, and cisplatin for adenoid cystic carcinoma, and their relationship with the pre-chemotherapy tumor growth rate.
    Ha H; Keam B; Ock CY; Heo DS
    Chin Clin Oncol; 2020 Apr; 9(2):15. PubMed ID: 32366107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic inhibition of Bmi-1 ablates chemoresistant cancer stem cells in adenoid cystic carcinoma.
    Sahara S; Warner KA; Herzog AE; Zhang Z; Nör JE
    Oral Oncol; 2023 Jul; 142():106437. PubMed ID: 37267716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitory effect of chidamide on the growth of human adenoid cystic carcinoma cells.
    Yang S; Nan P; Li C; Lin F; Li H; Wang T; Zhou C; Zhang X; Meng X; Qian H; Wang H; Dong M
    Biomed Pharmacother; 2018 Mar; 99():608-614. PubMed ID: 29710459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concomitant inhibition of epidermal growth factor and vascular endothelial growth factor receptor tyrosine kinases reduces growth and metastasis of human salivary adenoid cystic carcinoma in an orthotopic nude mouse model.
    Younes MN; Park YW; Yazici YD; Gu M; Santillan AA; Nong X; Kim S; Jasser SA; El-Naggar AK; Myers JN
    Mol Cancer Ther; 2006 Nov; 5(11):2696-705. PubMed ID: 17121916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of autophagy enhances cisplatin cytotoxicity in human adenoid cystic carcinoma cells of salivary glands.
    Ma B; Liang LZ; Liao GQ; Liang YJ; Liu HC; Zheng GS; Su YX
    J Oral Pathol Med; 2013 Nov; 42(10):774-80. PubMed ID: 23590333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of Recurrent or Metastatic Adenoid Cystic Carcinoma.
    de Sousa LG; Neto FL; Lin J; Ferrarotto R
    Curr Oncol Rep; 2022 May; 24(5):621-631. PubMed ID: 35212920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase II trial of dasatinib for recurrent or metastatic c-KIT expressing adenoid cystic carcinoma and for nonadenoid cystic malignant salivary tumors.
    Wong SJ; Karrison T; Hayes DN; Kies MS; Cullen KJ; Tanvetyanon T; Argiris A; Takebe N; Lim D; Saba NF; Worden FP; Gilbert J; Lenz HJ; Razak AR; Roberts JD; Vokes EE; Cohen EE
    Ann Oncol; 2016 Feb; 27(2):318-23. PubMed ID: 26598548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic Inhibition of the MDM2-p53 Interaction Prevents Recurrence of Adenoid Cystic Carcinomas.
    Nör F; Warner KA; Zhang Z; Acasigua GA; Pearson AT; Kerk SA; Helman JI; Sant'Ana Filho M; Wang S; Nör JE
    Clin Cancer Res; 2017 Feb; 23(4):1036-1048. PubMed ID: 27550999
    [No Abstract]   [Full Text] [Related]  

  • 10. Chemotherapy and targeted therapy in adenoid cystic carcinoma of the head and neck: a review.
    Papaspyrou G; Hoch S; Rinaldo A; Rodrigo JP; Takes RP; van Herpen C; Werner JA; Ferlito A
    Head Neck; 2011 Jun; 33(6):905-11. PubMed ID: 20652885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cisplatin-based chemotherapy in advanced adenoid cystic carcinoma of the head and neck.
    de Haan LD; De Mulder PH; Vermorken JB; Schornagel JH; Vermey A; Verweij J
    Head Neck; 1992; 14(4):273-7. PubMed ID: 1381339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AL101, a gamma-secretase inhibitor, has potent antitumor activity against adenoid cystic carcinoma with activated NOTCH signaling.
    Ferrarotto R; Mishra V; Herz E; Yaacov A; Solomon O; Rauch R; Mondshine A; Motin M; Leibovich-Rivkin T; Davis M; Kaye J; Weber CR; Shen L; Pearson AT; Rosenberg AJ; Chen X; Singh A; Aster JC; Agrawal N; Izumchenko E
    Cell Death Dis; 2022 Aug; 13(8):678. PubMed ID: 35931701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of autophagy augments chemotherapy in human salivary adenoid cystic carcinoma.
    Jiang L; Huang S; Zhang D; Zhang B; Li K; Li W; Zhang S; Zhang W; Zheng P
    J Oral Pathol Med; 2014 Apr; 43(4):265-72. PubMed ID: 24118359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term outcomes of neoadjuvant intra-arterial cytoreductive chemotherapy for lacrimal gland adenoid cystic carcinoma.
    Tse DT; Kossler AL; Feuer WJ; Benedetto PW
    Ophthalmology; 2013 Jul; 120(7):1313-23. PubMed ID: 23582989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BH3-mimetic small molecule inhibits the growth and recurrence of adenoid cystic carcinoma.
    Acasigua GA; Warner KA; Nör F; Helman J; Pearson AT; Fossati AC; Wang S; Nör JE
    Oral Oncol; 2015 Sep; 51(9):839-47. PubMed ID: 26121939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neoadjuvant intracarotid chemotherapy for treatment of advanced adenocystic carcinoma of the lacrimal gland.
    Meldrum ML; Tse DT; Benedetto P
    Arch Ophthalmol; 1998 Mar; 116(3):315-21. PubMed ID: 9514484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A phase 2 trial of bortezomib followed by the addition of doxorubicin at progression in patients with recurrent or metastatic adenoid cystic carcinoma of the head and neck: a trial of the Eastern Cooperative Oncology Group (E1303).
    Argiris A; Ghebremichael M; Burtness B; Axelrod RS; Deconti RC; Forastiere AA
    Cancer; 2011 Aug; 117(15):3374-82. PubMed ID: 21246525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic therapies for salivary gland adenoid cystic carcinoma.
    Sahara S; Herzog AE; Nör JE
    Am J Cancer Res; 2021; 11(9):4092-4110. PubMed ID: 34659878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclophosphamide, doxorubicin, and cisplatin in advanced salivary gland cancer.
    Debaere D; Vander Poorten V; Nuyts S; Hauben E; Schoenaers J; Schöffski P; Clement PM
    B-ENT; 2011; 7(1):1-6. PubMed ID: 21563549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenoid cystic carcinoma of the esophagus. Complete response to combination chemotherapy.
    Petursson SR
    Cancer; 1986 Apr; 57(8):1464-7. PubMed ID: 3004692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.